pegulicianine (Pending FDA Approval)

Brand and Other Names:Lumisight

Dosing & Uses

Tumor Imaging

Pegulicianine fluorescence–guided system (pFGS) is pending FDA approval for intraoperative margin assessment of the lumpectomy cavity to reduce residual disease or reexcision rate following standard of care breast-conserving surgery (BCS)

Next:

Pharmacology

Mechanism of Action

Intraoperative imaging agent

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.